Across TCGA pan-cancer cohorts, TRIM60P9Y RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated TRIM60P9Y data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher TRIM60P9Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRIM60P9Y expression acts as an unfavorable survival marker.

STAD and LAML are the cancer types where TRIM60P9Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.183	0.660	.009	72	view →
LAML	DFS	Tertile	All	0.165	0.577	.026	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: TRIM60P9Y tumor-vs-normal RNA expression · all TRIM60P9Y data types